Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP787874.RA7ZkODd-eNgZDI6JeFtPDN1tp8DuMZuNkuR6EO9VAzdA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP787874.RA7ZkODd-eNgZDI6JeFtPDN1tp8DuMZuNkuR6EO9VAzdA130_assertion type Assertion NP787874.RA7ZkODd-eNgZDI6JeFtPDN1tp8DuMZuNkuR6EO9VAzdA130_head.
- NP787874.RA7ZkODd-eNgZDI6JeFtPDN1tp8DuMZuNkuR6EO9VAzdA130_assertion description "[In follow-up analyses of the sample of patients, the prognostic value of securin was compared with the established markers of breast cancer proliferation, Ki-67 and mitotic activity index (MAI).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP787874.RA7ZkODd-eNgZDI6JeFtPDN1tp8DuMZuNkuR6EO9VAzdA130_provenance.
- NP787874.RA7ZkODd-eNgZDI6JeFtPDN1tp8DuMZuNkuR6EO9VAzdA130_assertion evidence source_evidence_literature NP787874.RA7ZkODd-eNgZDI6JeFtPDN1tp8DuMZuNkuR6EO9VAzdA130_provenance.
- NP787874.RA7ZkODd-eNgZDI6JeFtPDN1tp8DuMZuNkuR6EO9VAzdA130_assertion SIO_000772 18594525 NP787874.RA7ZkODd-eNgZDI6JeFtPDN1tp8DuMZuNkuR6EO9VAzdA130_provenance.
- NP787874.RA7ZkODd-eNgZDI6JeFtPDN1tp8DuMZuNkuR6EO9VAzdA130_assertion wasDerivedFrom befree-20140225 NP787874.RA7ZkODd-eNgZDI6JeFtPDN1tp8DuMZuNkuR6EO9VAzdA130_provenance.
- NP787874.RA7ZkODd-eNgZDI6JeFtPDN1tp8DuMZuNkuR6EO9VAzdA130_assertion wasGeneratedBy ECO_0000203 NP787874.RA7ZkODd-eNgZDI6JeFtPDN1tp8DuMZuNkuR6EO9VAzdA130_provenance.